Dr. Carrie L. Lucas received her PhD from Harvard Medical School and her postdoctoral training from the National Institutes of Health, NIAID. Her laboratory discovers single-gene defects underlying severe immune disorders in humans and investigates mechanisms using patient cells and genetically engineered mouse models. A major focus of her work has been on phosphoinositide 3-kinase (PI3K) signaling and mechanisms of disease in immunodeficient patients with mutations in PI3K subunits.
| Award | Awarding Organization | Date |
|---|---|---|
| Christina Fleischmann Award to Young Women Investigators | International Cytokine & Interferon Society | 2020 |
| CRI CLIP Award | Cancer Research Institute | 2019 |
| Bohmfalk Scholar, Yale School of Medicine | 2018 | |
| Charles Hood Foundation: Child Health Research Award | 2017 | |
| Keystone Symposia Future of Science Award | 2015 | |
| K99/R00 Pathway to Independence Award | 2015 | |
| Ray Owen Young Investigator Award | 2014 | |
| AAI-Life Technologies Trainee Achievement Award | 2014 | |
| Goldwater Scholar | 2005 |